Summary

This report provides an update on IPD for the 12 months commencing in January 2021. Data presented in this report are based on IPD case notifications supplemented with serotype and antimicrobial susceptibility data from ESR’s national laboratory-based surveillance of invasive Streptococcus pneumoniae isolates.